Diplomat Pharmacy

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch DPLO and buy or sell other stocks, ETFs, and their options commission-free!

About DPLO

Diplomat Pharmacy, Inc. engages in the provision of specialty pharmacy and infusion services. It operates under the Specialty and Pharmacy Benefit Management (PBM) segments. 

CEO
Brian T. Griffin
CEOBrian T. Griffin
Employees
Employees
Headquarters
Flint, Michigan
HeadquartersFlint, Michigan
Founded
1975
Founded1975
Employees
Employees

DPLO Key Statistics

Market cap
303.90M
Market cap303.90M
Price-Earnings ratio
-0.46
Price-Earnings ratio-0.46
Dividend yield
Dividend yield
Average volume
578.82K
Average volume578.82K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$14.46
52 Week high$14.46
52 Week low
$2.43
52 Week low$2.43

Stock Snapshot

Diplomat Pharmacy(DPLO) stock is priced at $4.00, giving the company a market capitalization of 303.9M. It carries a P/E multiple of -0.46.

On 2026-02-07, Diplomat Pharmacy(DPLO) stock opened at —, reached a high of —, and a low of —.

Diplomat Pharmacy(DPLO) shares are trading with a volume of 0, against a daily average of 578.82K.

During the past year, Diplomat Pharmacy(DPLO) stock moved between $2.43 at its lowest and $14.46 at its peak.

During the past year, Diplomat Pharmacy(DPLO) stock moved between $2.43 at its lowest and $14.46 at its peak.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.